News
There's plenty of reason to be optimistic about Synopsys' future; however, whether it could realistically make you a ...
3d
Zacks.com on MSNSynopsys (SNPS) Stock Sinks As Market Gains: What You Should KnowIn the most recent trading session, Synopsys (SNPS) closed at $601.55, indicating a -1.33% shift from the previous trading day.
12d
Zacks.com on MSNSynopsys (SNPS) Moves 3.6% Higher: Will This Strength Last?Synopsys (SNPS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
This was the stock's fourth consecutive day of losses.
Researchers evaluated the relative importance of phenotypic and genetic factors in predicting risk for head and neck cancer.
Goldman Sachs highlighted that a broadening customer base continues to drive outsized growth in Synopsys, Inc.
The recently passed One Big Beautiful Bill Act (OBBBA) could have a disproportionate impact on nursing home residents ...
4d
Zacks Investment Research on MSNIs Trending Stock Synopsys, Inc. (SNPS) a Buy Now?Synopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Buying $1000 In SNPS: If an investor had bought $1000 of SNPS stock 15 years ago, it would be worth $26,611.09 today based on a price of $587.59 for SNPS at the time of writing.
Billionaire Kerr Neilson has bought over $1.4 million worth of shares in Synopsys, Inc. (NASDAQ: SNPS ), representing 0.08% ...
4d
News-Medical.Net on MSNAI identifies novel gene variants linked to Alzheimer’s riskThis study reveals how machine learning models uncover new genetic variants linked to Alzheimer’s, advancing predictive ...
In the preceding three months, 8 analysts have released ratings for Synopsys SNPS +0.81% Get Free Report , presenting a wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results